|
SERP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.72210000000717E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74099999999955E-05 |
| Normal-vs-Stage2 |
1.612000E-01 |
| Normal-vs-Stage3 |
3.57659999999926E-05 |
| Normal-vs-Stage4 |
4.184000E-03 |
| Stage1-vs-Stage2 |
2.060200E-01 |
| Stage1-vs-Stage3 |
4.851200E-01 |
| Stage1-vs-Stage4 |
2.368800E-01 |
| Stage2-vs-Stage3 |
9.813600E-02 |
| Stage2-vs-Stage4 |
5.994200E-01 |
| Stage3-vs-Stage4 |
1.197590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.56360000000256E-05 |
| Normal-vs-AfricanAmerican |
2.79070000441806E-08 |
| Normal-vs-Asian |
1.382460E-03 |
| Caucasian-vs-AfricanAmerican |
5.101100E-03 |
| Caucasian-vs-Asian |
1.354020E-01 |
| AfricanAmerican-vs-Asian |
1.889610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76460000000933E-06 |
| Normal-vs-Female |
2.343000E-03 |
| Male-vs-Female |
7.416500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.880200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.014420E-04 |
| Normal-vs-Age(61-80Yrs) |
1.434680E-04 |
| Normal-vs-Age(81-100Yrs) |
4.423000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.224800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.824200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.862400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.373600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.160400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.648000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.500200E-02 |
| Normal-vs-Grade 2 |
1.641030E-03 |
| Normal-vs-Grade 3 |
5.62720000041317E-07 |
| Normal-vs-Grade 4 |
1.962350E-04 |
| Grade 1-vs-Grade 2 |
5.744000E-01 |
| Grade 1-vs-Grade 3 |
7.548600E-01 |
| Grade 1-vs-Grade 4 |
7.440400E-01 |
| Grade 2-vs-Grade 3 |
8.440200E-02 |
| Grade 2-vs-Grade 4 |
2.345400E-01 |
| Grade 3-vs-Grade 4 |
9.343000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.495500E-03 |
| Normal-vs-ccB subtype |
1.71605999998992E-05 |
| ccA subtype-vs-ccB subtype |
9.705900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.158300E-04 |
| Normal-vs-N1 |
3.925800E-01 |
| N0-vs-N1 |
2.062000E-01 |
|
|
